These results strongly suggest that specific targeting metabolic pathways of MDSCs such as lipid metabolic pathway and mTOR pathway without affecting other cells would be a new promising therapeutic approach to control solid tumor as well as glioblastoma progression. The gene discussed is MTOR; the disease is glioblastoma.